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ABSTRACT 
 
Bird flu vaccine from H5N1 strain of avian influenza virus was prepared with two concentrations of 
adjuvant (Montanide ISA 70MVG). Two vaccines (I and II) were prepared containing 50 and 60% 
Montanide, respectively. Immune response of both the vaccines as single, as well as booster, dose was 
evaluated in layer birds through haemagglutination inhibition test. Single dose of both vaccines showed 
poor immune response, while booster dose gave better response with both the vaccines. However, the 
vaccine prepared with 60% Montanide provided better immune response compared with the vaccine 
containing 50% montanide. 
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INTRODUCTION 
 
Avian influenza is one of the highly contagious 
Office of International Epizootics (OIE) list “A” 
diseases. This diseases is also called as “fowl plague” 
due to its high mortality in chicken. It has emerged as a 
disease with significant potential to affect commercial 
poultry production, resulting in extensive losses. Avian 
influenza is caused by influenza “A” virus which 
belongs to family orthomyxoviridae. It is a negative 
stranded, segmented RNA virus with 16 haemagglutin 
and 9 neuraminidase types. H5N1 is the causative agent 
of avian flu and is endemic in many bird populations. It 
is characterized by nasal and lacrimal discharge, 
reddening of legs and comb, facial swelling, off feed 
and death. Migratory birds like waterfowl, are known to 
carry different subtypes of avian flue.  
Avian influenza has been prevailing in Pakistan 
since 1994 (Muhammad, 2006). Early incidence of 
H5N1 was reported in two poultry farms at Charsada and 
Abbotabad in Northern areas of the country in 
February, 2006. Human mortality has also been 
recorded due to H5N1 (Subbarao, 1997; Sims et al., 
2003). Aqueous vaccine against H5N1 virus has 
effectively controlled the disease in the vaccinated 
flock but due to quick absorption, immunity produced 
was of shorter duration and frequent booster doses are 
needed. Keeping in view the duration of immunity and 
to avoid stress to the birds by repeating aqueous 
vaccine, an economical and quality oil based avian 
influenza vaccine from local strain of avian influenza 
virus subtype H5N1  (A/chicken/Pakistan/ NARC-
2238106) was prepared by using two concentrations of 
adjuvant.  
 
MATERIALS AND METHODS 
 
Avian influenza virus (H5N1) was grown in 10-day 
old chicken embryonated eggs. The embryos showing 
death within 36-48 hours was chilled at 4
oC and their 
chorioallantoic fluid (CAF) was harvested. Sterility test, 
haemagglutination test and embryo lethal dose 
50(ELD50) of the CAF was determined (Allan et al., 
1978). The CAF was kept at 4
oC for 48 hours after 
addition of formalin (0.12%) and later examined for 
safety and sterility, as described by Allan et al. (1978).  
Two batches of oil-based vaccines were prepared 
using Montanide 50% (vaccine-I) and 60% 
concentration (vaccine-II). Thirty layer birds were 
procured from poultry unit of Veterinary Research 
Institute, Lahore, Pakistan. Ten pullets were bled at 
random to check the status of birds against avian 
influenza virus. The birds were divided into three 
groups A, B and C with 10 birds in each group. Layers 
of groups A and B were inoculated with vaccine-I and 
II, respectively @ 0.3 ml/ pullet intramuscularly. Layer 
birds of group C were kept as control. After 21 days of 
primary vaccines, the birds of both vaccinated groups 
were bled to determine the single dose titre along with 
the control group for comparison. 
After first bleeding, each vaccinated group was 
divided into two subgroups as A, A1, B and B1. The 
birds of A1 and B1 subgroups were given booster dose 
with vaccine I and II, respectively. Blood samples were 
collected from birds of both groups (single and booster 
dose) after 30, 60, 90 and 120 days post vaccination. 
Serum was separated  from  each  sample  and stored at 
-20
oC till processing for haemagglutination inhibition 
(HI) test.  
The HI antibody titre was determined following the 
method described by Allan et al. (1978). Geometric 
mean titre (GMT), cumulative GMT (CGMT) and 
standard deviation (SD) of HI antibodies of each group 
were determined and compared following Villages and 
Purchase (1980).  Pakistan Vet. J., 2008, 28(4): 205-206.  206
 
Table 1: Haemagglutination inhibition titre of various groups of vaccinated birds 
Day  Control  Vaccine I, single 
dose 
Vaccine II, single 
dose 
Vaccine I, booster 
dose 
Vaccine II, booster 
dose 
0  0  0 0 0  0 
30 0  12.1  13.90  --  -- 
60 0  10.6  10.60  27.90  34.20 
90  0  6.10    8.00  18.40  24.30 
120  0  4.20    6.10  16.00  18.40 
CGMT*  --  8.25    9.65  20.67  25.60 
SD**  --  3.20    2.92    5.13    6.51 
*=Cumulative geometric mean titre. ** =Standard deviation.     
 
RESULTS AND DISCUSSION 
 
The HI titres of birds with single shot of vaccines I 
and II at days 30, 60, 90 and 120 were 12.1: 13.9; 10.6, 
10.6; 6.1: 8.0; and 4.2: 6.1 respectively. While, the HI 
titres of birds with booster shot of vaccine I and II at 
days  60, 90 and 120 were 27.9, 34.2; 18.4, 24.3 and 
16.0, 18.4 respectively. No titre was noted in control 
birds (Table I). 
These results show that when the oil based avian 
influenza vaccine was given as single shot, the 
maximum HI titre of birds was observed for both 
vaccines I and II at day 30. After that, HI titre declined 
for both vaccines and reached 4.2 and 6.1 for vaccine I 
and II, respectively, at day 120.  
The results of birds boosted with 50 and 60% 
montanide vaccines showed high HI titre at day 60. 
After that, it rapidly declined in 50% montanide to 18.4 
and 16.0 at day 90 and 120, respectively, compared 
with 24.3 and 18.4 at day 90 and 120, respectively, for 
60% montanide. The GMT of the vaccine having 
adjuvant concentration 60% was higher compared to 
the vaccine having 50% concentration of the adjuvant. 
These results are in line with Tizzard (1996), who 
found that adjuvat promoted immunogenicity when 
added to the vaccine.  
In the present study, it was noted that oil based 
avian influenza vaccine produced high protective titre, 
Ayesha et al. (2005) also reported higher HI titre with 
oil based avian influenza vaccine compared to alum 
precipitated and alum hydroxide gel containing 
vaccines. Similarly, adjuvanted vaccine of Newcastle 
disease enhanced immune response for longer duration 
(Iqbal et al., 2003).      
In conclusion, single shot of oil based avian 
influenza vaccine did not confer protective immune 
response but boost shot of vaccine confered the 
protective immune response for longer duration. 
Furthermore, oil based vaccine prepared with 60% 
montanide provided higher GMT than that with 50% 
montanide concentration.  
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